Kerry D. Ingalls Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Kerry D. Ingalls is Chief Operating Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 55,000 shares of PSTX, which is worth approximately $519,749. The most recent transaction as insider was on Mar 16, 2022, when has been sold 3,000 shares (Common Stock) at a price of $3.98 per share, resulting in proceeds of $11,940. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55K
0% 3M change
0% 12M change
Total Value Held $519,749

Kerry D. Ingalls Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2022
BUY
Open market or private purchase
$11,940 $3.98 p/Share
3,000 Added 5.17%
55,000 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 49.02%
52,000 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$14,000 $7.0 p/Share
2,000 Added 50.0%
2,000 Common Stock
KDI

Kerry D. Ingalls

Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX